• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment


203.2500 USD 1.5700 0.78%

As of 16:00:00 ET on 01/27/2015.

Snapshot for Illumina Inc (ILMN)

Open: 199.5900 Day's Range: 197.0200 - 206.0000 Volume: 1,648,950
Previous Close: 201.6800 52wk Range: 127.6900 - 206.0000 1-Yr Rtn: +44.92%

Stock Chart for ILMN

No chart data available.
  • ILMN:US 203.2000
  • 1D
  • 1M
  • 1Y
Interactive ILMN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ILMN

Current P/E Ratio (ttm) 76.7771
Estimated P/E(12/2015) 63.9849
Relative P/E vs. SPX 4.4038
Earnings Per Share (USD) (ttm) 2.6449
Est. EPS (USD) (12/2015) 3.1770
Est. PEG Ratio 2.6946
Market Cap (M USD) 28,835.94
Shares Outstanding (M) 142.00
30 Day Average Volume 1,351,345
Price/Book (mrq) 22.6487
Price/Sale (ttm) 14.8185
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 01/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ILMN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ILMN

Illumina, Inc. develops, manufactures and markets integrated systems for the large scale analysis of genetic variation and biological function. The Company provides a comprehensive line of products and services that currently serve the sequencing, genotyping and gene expression markets for genomic research centers, pharmaceutical companies, academic institutions and biotechnology companies.

Jay T FlatleyChief Executive OfficerFrancis A DesouzaPresident
Marc A StapleySenior VP/CFOMostafa RonaghiSenior VP/CTO
More Company Profile & Key Executives for ILMN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil